Contrast enhanced ultrasound a novel technique in lymphatic imaging - A prospective study

Status

Not yet recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519077-19-01

Enrollment

100

Registered

2024-12-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphatic Imaging

Brief summary

Visualization of the superficial lymphatic vessels after the injection of the ultrasound contrast agent

Interventions

DRUGSonazoid 8 mikroliter per ml pulver og væske til injeksjonsvæske

DRUGdispersjon

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Visualization of the superficial lymphatic vessels after the injection of the ultrasound contrast agent	—

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026